Selling And Administration Expenses Zmiana
Abbvie ABBV:US $ 3.09B 254M
Amgen AMGN:US $ 1.77B 427M
Aphria Inc APH:CN C$ 54.2M 8.26M
AstraZeneca AZN:LN 2.63B 357M
Bristol Myers Squibb BMY:US $ 2.72B 1.01B
Canopy Growth Corp WEED:CN C$ 142.71M 8.48M
Catalent CTLT:US $ 165.5M 800K
Eli Lilly And LLY:US $ 1.55B 15.2M
Endo International Ordinary Shares ENDP:US 182.26M 9M
GlaxoSmithKline GSK:LN 2.92B 447M
Glaxosmithkline GSK:US 2.92B 447M
Gw Pharmaceuticals GWPH:US 85.2M 9.31M
Johnson & Johnson JNJ:US $ 6.46B 1.03B
Lannett LCI:US $ 13.73M 1.41M
Novartis NOVN:VX 3.91B 590M
Pacira Pharmaceuticals PCRX:US $ 52.56M 9.22M
Perrigo Ordinary Shares PRGO:US 280.9M 13.5M
Pfizer PFE:US $ 3.59B 716M
Phibro Animal Health PAHC:US $ 48.38M 56K
Supernus Pharmaceuticals SUPN:US $ 54.66M 13.96M
Takeda 4502:JP 216.26B 13.88B
Teva Pharmaceutical TEVA:IT 965M 112M
Valeant Pharmaceuticals VRX:CN C$ 572M 46M
Zoetis ZTS:US $ 520M 96M



Glaxosmithkline Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2021.